Andreas Timmermann

ORCID: 0000-0003-2726-4420
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cytokine Signaling Pathways and Interactions
  • Cell Adhesion Molecules Research
  • Comparative constitutional jurisprudence studies
  • Osteoarthritis Treatment and Mechanisms
  • Protease and Inhibitor Mechanisms
  • Cancer Research and Treatments
  • Radical Photochemical Reactions
  • Human Rights and Immigration
  • European history and politics
  • Historical Studies in Latin America
  • Immune Response and Inflammation
  • Organoboron and organosilicon chemistry
  • HER2/EGFR in Cancer Research
  • Melanoma and MAPK Pathways
  • Tendon Structure and Treatment
  • Political Theory and Democracy
  • International Environmental Law and Policies
  • Sphingolipid Metabolism and Signaling
  • Advanced Glycation End Products research
  • CAR-T cell therapy research
  • Blood Coagulation and Thrombosis Mechanisms
  • Cellular transport and secretion
  • Lipid Membrane Structure and Behavior
  • Knee injuries and reconstruction techniques
  • American Constitutional Law and Politics

Bayer (Germany)
2014-2021

German Federal Chancellery
2010

Junta de Castilla y León
2010

Bayer (United States)
2009

University of Baltimore
2007

Mount Sinai Hospital
2006

Lunenfeld-Tanenbaum Research Institute
2006

University Hospital Bonn
2005

RWTH Aachen University
1999-2002

Philipps University of Marburg
2001

Abstract Objective Matrix metalloproteinases (MMPs) have long been considered excellent targets for osteoarthritis (OA) treatment. However, clinical utility of broad‐spectrum MMP inhibitors developed this purpose has restricted by dose‐limiting musculoskeletal side effects observed in humans. This study was undertaken to identify a new class potent and selective MMP‐13 that would provide histologic efficacy without toxicity. Methods Selectivity assays were using catalytic domains human MMPs....

10.1002/art.24629 article EN Arthritis & Rheumatism 2009-06-29

[reaction: see text] A new method for mild metal-free hydrosilylation is described. Silylated cyclohexadienes are used as radical transfer hydrosilylating reagents various double and triple bonds. trialkylsilane transferred from a cyclohexadiene moiety to an alkene. The can be combined with C-C bond formation shown the preparation of silylated cycloalkanes corresponding dienes.

10.1021/ol016160c article EN Organic Letters 2001-06-19

Abstract The transmembrane glycoprotein gp130 is the common signal transducing receptor subunit of IL-6-type cytokines. extracellular part predicted to consist six individual domains. Whereas role three membrane-distal domains (D1–D3) in binding IL-6 and IL-11 well established, function membrane-proximal (D4–D6) unclear. Mapping a neutralizing mAb suggests functional D4–D6 activation. Individual deletion these differentially interferes with ligand soluble membrane-bound receptors. All...

10.4049/jimmunol.164.1.273 article EN The Journal of Immunology 2000-01-01

gp130 is the common signal transducing receptor subunit of interleukin (IL)‐6‐type cytokines. either homodimerizes in response to IL‐6 and IL‐11 or forms heterodimers with leukemia inhibitory factor (LIF) (LIFR) LIF, oncostatin M (OSM), ciliary neurotrophic (CNTF), cardiotrophin‐1 (CT‐1) cardiotrophin‐like cytokine resulting onset cytoplasmic tyrosine phosphorylation cascades. The extracellular parts both LIFR consist several Ig‐like fibronectin type III‐like domains. role membrane‐distal...

10.1046/j.1432-1033.2002.02941.x article EN European Journal of Biochemistry 2002-05-21

Leukaemia inhibitory factor (LIF) signals via a heterodimeric receptor complex comprised of the LIF (LIFR) and interleukin (IL)-6 signal transducer gp130. Upon binding to its cognate is internalized. In this study, we show that LIFR endocytosed independently By using heterochimaeric system identified dileucine-based internalization motif within cytoplasmic domain LIFR. Our findings suggest LIFR/gp130 homodimeric gp130/gp130 are distinct signals.

10.1042/bj3390015 article EN Biochemical Journal 1999-03-25

Gp130 is the common signal transducing receptor subunit of interleukin (IL)‐6, IL‐11, leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic and cardiotrophin‐1. IL‐6 IL‐11 induce gp130 homodimerization whereas others lead to formation heterodimers with LIFR or OSMR. Binding epitopes for are located in immunoglobulin‐like domain cytokine binding module (CBM). Here we show that a mutant lacking 1, although unresponsive can still activate transducer activator transcription...

10.1016/s0014-5793(00)01205-9 article EN FEBS Letters 2000-02-22

10.12946/rg16/066-068 article Rechtsgeschichte - Legal History 2010-01-01

Leukaemia inhibitory factor (LIF) signals via a heterodimeric receptor complex comprised of the LIF (LIFR) and interleukin (IL)-6 signal transducer gp130. Upon binding to its cognate is internalized. In this study, we show that LIFR endocytosed independently By using heterochimaeric system identified dileucine-based internalization motif within cytoplasmic domain LIFR. Our findings suggest LIFR/gp130 homodimeric gp130/gp130 are distinct signals.

10.1042/0264-6021:3390015 article EN Biochemical Journal 1999-04-01

VRÜ Verfassung und Recht in Übersee , Seite 46 - 69

10.5771/0506-7286-2010-1-46 article DE Verfassung in Recht und Übersee 2010-01-01

VRÜ Verfassung und Recht in Übersee , Seite 176 - 198

10.5771/0506-7286-2007-2-176 article DE Verfassung in Recht und Übersee 2007-01-01

VRÜ Verfassung und Recht in Übersee , Seite 78 - 104

10.5771/0506-7286-2005-1-78 article DE Verfassung in Recht und Übersee 2005-01-01

Abstract Cancer cells typically display altered glucose metabolism characterized by a preference of aerobic glycolysis (Warburg effect) resulting in higher levels glycolytic waste including methylglyoxal (MG). GLO1 (Glyoxalase 1) functions the detoxification MG: MG reacts with glutathione to form hemithioacetal, which is converted into S-D-Lactoylglutathione and further metabolised D-lactate GLO2. When not detoxified, acts as cytotoxic reagent forming DNA- protein-adducts (advanced glycation...

10.1158/1538-7445.am2014-3355 article EN Cancer Research 2014-10-01

10.1628/joer-2012-0027 article DE Jahrbuch des öffentlichen Rechts der Gegenwart Neue Folge 2012-01-01

"Law and Politics in Africa, Asia Latin America" analyses legal constitutional developments all states or regions outside of Europe as well their regional international integration. Founded 1968 inspired by decolonization the idea a cooperative new beginning, Journal also promotes special interest contributions on 'Law development'. The journal aims to provide forum for variety perspectives these fields interest, be they focused one country comparative, theoretical methodological nature.

10.5771/0506-7286-1999-3-314 article EN cc-by Verfassung in Recht und Übersee 1999-01-01

10.1628/joer-2018-0029 article DE Jahrbuch des öffentlichen Rechts der Gegenwart Neue Folge 2018-01-01

Einleitung: Dendritische Zellen können antigenspezifische T-Zellen gegen Tumorantigene stark stimulieren. Ihr Ansatz das hepatozelluläre Karzinom (HCC) hat allerdings bisher nur begrenzten Erfolg gezeigt. Die Verwendung von potenten Immunmodulatoren wie CD40L könnte die antitumorale Wirkung DC HCC steigern. Unser Ziel in dieser Arbeit war zu prüfen, ob sich immunstimulatorische mit Tumorlysat beladenen mittels Transduktion CD40L-Adenovirus verstärken lässt.

10.1055/s-2005-862291 article DE Zeitschrift für Gastroenterologie 2005-01-14
Coming Soon ...